Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.
Récher C, Dumas PY, Bérard E, Tavitian S, Leguay T, Galtier J, Alric C, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Luquet I, Klein E, de Grande AC, Sarry A, Zukunft S, Platzbecker U, Müller-Tidow C, Baldus CD, Bornhäuser M, Serve H, Bertoli S, Pigneux A, Röllig C.
Récher C, et al. Among authors: rieu jb.
Am J Hematol. 2025 Jan;100(1):23-32. doi: 10.1002/ajh.27510. Epub 2024 Nov 18.
Am J Hematol. 2025.
PMID: 39555737
Free PMC article.